Skip to main content
Loading

Resolution Therapeutics

Monday, February 26, 2024
Plymouth
Gene/Cell Therapy
Pioneering marcrophage cell therapy to transform the outcomes of patients with End Stage Liver Disease
Speakers
Amir Hefni, CEO - Resolution Therapeutics

Country

United Kingdom

Website

https://resolution-tx.com/

CEO/Top Company Official

Amir Hefni

Lead Product in Development

RTX001, autologous engineered macrophage cell therapy

Development Phase of Primary Product

Phase I

Number Of Unlicensed Products

2
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP